Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics

Quantification of clonal circulating plasma cells in relapsed multiple myeloma

(2014) Wilson I. Gonsalves et al.   BRITISH JOURNAL OF HAEMATOLOGY

Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma

(2014) W I Gonsalves et al.   LEUKEMIA

Klinik und Therapie des multiplen Myeloms

(2014) E.K. Mai et al.   RADIOLOGE

Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile

(2013) B. Paiva et al.   BLOOD

High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma

(2012) G Bianchi et al.   LEUKEMIA

High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma

(2011) B. Paiva et al.   BLOOD

Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2

(2011) N. C. Munshi et al.   BLOOD

The prognostic significance of cytogenetics and molecular profiling in multiple myeloma

(2011) Jeffrey R. Sawyer   Cancer Genetics

Multiple Myeloma

(2009) S. Vincent Rajkumar   CURRENT PROBLEMS IN CANCER

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

(2008) R A Kyle et al.   LEUKEMIA